This report contains market size and forecasts of Emergency Hemostatic Agent in global, including the following market information:
Global Emergency Hemostatic Agent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Emergency Hemostatic Agent Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Emergency Hemostatic Agent companies in 2021 (%)
The global Emergency Hemostatic Agent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gelation Sponge Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Emergency Hemostatic Agent include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences and B Braun Melsungen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Emergency Hemostatic Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Emergency Hemostatic Agent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Emergency Hemostatic Agent Market Segment Percentages, by Type, 2021 (%)
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Global Emergency Hemostatic Agent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Emergency Hemostatic Agent Market Segment Percentages, by Application, 2021 (%)
Hospitals
Surgical Centers
Clnics
Others
Global Emergency Hemostatic Agent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Emergency Hemostatic Agent Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Emergency Hemostatic Agent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Emergency Hemostatic Agent revenues share in global market, 2021 (%)
Key companies Emergency Hemostatic Agent sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Emergency Hemostatic Agent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS